Efficacy and safety of ureteral stent placement as a preoper
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Ureteral stent placement (USP) preoperatively for gynecological cancer surgeries is linked with more chances of bladder tamponade and hydronephrosis postoperatively.

The study was aimed to evaluate the efficacy and safety of ureteral stent placement (USP) as a preoperative procedure for gynecological cancer surgeries.

This was a single?institution retrospective cohort study of 259 patients with gynecological cancer who underwent laparotomy. In 126 patients (USP+ group), a ureteral stent was inserted into the bilateral ureters after the induction of general anesthesia. The remaining 133 patients (USP? group) did not undergo USP.

Researchers compared operation time, blood loss, and frequency of laparotomy?related perioperative urinary complications between the groups. The stent was removed 5–7?days postoperatively. Patients were evaluated for signs of hydronephrosis at discharge.

--There were no significant differences in age and BMI between the groups.

--Two patients in the USP? group experienced an intraoperative ureteral injury.

--Total operation time and blood loss were significantly increased in the USP+ group.

--The risk of bladder tamponade and postoperative hydronephrosis was influenced by USP. USP was unaffected by a history of abdominal surgery, stage of tumor progression, lymphadenectomy type, or hysterectomy type.

Conclusively, the incidence of bladder tamponade and hydronephrosis postoperatively was significantly higher in patients with USP than in those without USP.

Source: https://doi.org/10.1111/jog.14829
Like
Comment
Share